Untapping The Huge Dental AI Market For Everyone!
SMILE Dx empowers dentists to diagnose cavities, PAPs and peridontal disease on the pixel level.
Patient who see their x-rays in AI are
significantly more likely to accept treatment. 1
Patient who see their x-rays in AI are significantly more likely to accept treatment 1.
"RED…. that can’t be good"
Dental AI will profoundly transform the dental field.
Dentist will have the technology to detect cavities, gum disease, and root canals on the pixel level. The days of “watching” a cavity get larger are over.
No physician ever told a patient “lets watch this cancer”. Early detection and conservative treatment is the only ethical solution.
No physician ever told a patient “lets watch this cancer”. Early detection and conservative treatment is the only ethical solution.
Venture Capitalists have already invested HUNDREDS of MILLIONS of dollars in dental AI2,3,4.
They will never offer this opportunity to individual investors until they are exiting.
They will never offer this opportunity to individual investors until they are exiting.
There are 202,3045 practicing dentists in the United States.
There are 1.4 BILLION dental X-Rays taken in America each year.6
If 5% of the United States dentists subscribe to Smile Dx
Top line revenue will be over 60 million dollars per year!!!
SMILE Dx is Now
FDA Approved!
The team is committed to rewarding our shareholders with strategic exit options.
MARKET VALUATION
If SMILE Dx captures 1-2% of the 3.1 Billion Dental AI imaging market.
A Conservative SMILE Dx Valuation:
$31M revenue x 5x multiple equals a $155 million valuation.
An Optimistic SMILE Dx Valuation:
$62M revenue x 10x multiple equals a $620 million valuation.
OUR TEAM GOT SMILE Dx BUILT ON TIME AND ON BUDGET
RICHARD RICCI, DDS
Chief Executive Officer
ANDREA R.CAMBRIA, DDS
Chief Financial Officer
YUJAN SHRESTHA, MD
AI Team Leader
ETHAN ULRICH, BS
Computer Vision Engineer
JOSHUA TZUCKER, BA
Software Engineer
SETH T LIRETTE, PH.D.
Biostatic Adviser
MERI MARTINEZ, BA
FDA Regulatory Consultant
MARY VATER, BA
FDA Regulatory Consultant
FOUNDERS COMMITMENT
Founders built Smile Dx with their own money.
We have no venture capital debt.
Founders NEVER took a salary.
